ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 746058 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 746058; 2) Community: the network communities that were significantly associated with the response to NSC 746058; 3) Molecule: the relationships between components within communities and NSC 746058; 4) MDR: the compounds that were significantly associated with the NSC 746058.

NSC Compound Enrichment Correlation
NSC 743853 Null 0.0454469012959173 0.38394671
NSC 744650 Null 0.0454469012959173 0.46698895
NSC 745591 Null 0.0454469012959173 -0.097362234
NSC 746035 2-4-[(5-2,6-dimethoxy-4-[5-(3,4,5-trimethoxyphenyl)-4,5-dihydro-3-isoxazolyl]phenoxypentyl)oxy]-3-methoxyphenyl-1,2,3,4-tetrahydro-4-quinazolinone 0.0454469012959173 0.27648297
NSC 102810 D-ARABINOSE, 5-O-TRITYL-TRIBENZOATE 0.0459335986102865 0.43401794
NSC 123463 Ethanesulfonic acid, compd. with 4-[3-[p-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)benzyl]ureido]-o-toluenesulfonyl fluoride (1:1) (8CI) 0.0459335986102865 0.37462521
NSC 150862 BLEOMYCIN FRACTION BLM-HPE 0.0459335986102865 -0.016824979
NSC 155693 6H-Pyrido[4,3-b]carbazolium, 9-methoxy-2,5,11-trimethyl-,iodide 0.0459335986102865 -0.18168511
NSC 176503 Fastigilin B 0.0459335986102865 0.35473163
NSC 194124 Piperidinium, 1,1-didodecyl-3-methyl-, bromide 0.0459335986102865 0.26608469
Total:142  Current:130    [First] [Prev] [Next] [Last]